Randomized Comparison of Efficacy and Safety of High-intensity Rosuvastatin/Ezetimibe Combination Versus Treat-to-target Rosuvastatin Monotherapy for Patients With Peripheral Artery or Polyvascular Disease (CARE-PVD Trial)

Conditions: Peripheral Artery Disease; Polyvascular Disease Interventions: Drug: Combination therapy of high-intensity dose rosuvastatin and ezetimibe; Drug: Rosuvastatin monotherapy for treat-to-target Sponsors: Yonsei University Not yet recruiting

https://clinicaltrials.gov/study/NCT06231966

Source: ClinicalTrials.gov - January 30, 2024 Category: Research Source Type: clinical trials